AADI

AADI

USD

Aadi Bioscience Inc. Common Stock

$2.050-0.100 (-4.651%)

实时价格

Healthcare
生物技术
美国

价格图表

无可用图表数据

关键指标

市场指标
公司基本面
交易统计

市场指标

开盘价

$2.150

最高价

$2.190

最低价

$2.015

成交量

N/A

公司基本面

市值

94.9M

所属行业

生物技术

国家/地区

United States

交易统计

平均成交量

0.19M

交易所

NCM

货币

USD

52周价格范围

最低价 $1.21当前价 $2.050最高价 $3.812

AI分析报告

最后更新: 2025年4月13日
由AI生成数据来源: Yahoo Finance, Bloomberg, SEC

[AADI: Aadi Bioscience Inc. Common Stock]: Checking the Pulse - What's Next for AADI?

Stock Symbol: AADI Generate Date: 2025-04-13 01:11:18

Let's take a quick look at Aadi Bioscience (AADI) stock. For folks who aren't glued to financial news all day, we're going to break down what's been happening and what it might mean without getting lost in complicated Wall Street talk.

Recent News Buzz: Earning Results on the Horizon

The latest news is pretty straightforward: Aadi Bioscience is going to announce their results for the last quarter of 2024 and the full year. Think of it like a report card for the company's financial performance. They're holding a webcast to discuss it. Generally, this kind of news is a moment investors pay attention to. It's a chance to see how the company is actually doing and what they expect for the future. No immediate fireworks in this news itself, but it sets the stage for potential movement depending on what those results actually say.

Price Check: A Bit of a Downturn Lately

If you look at the stock price over the last month or so, it's been mostly trending downwards. Starting back in mid-January, we saw prices around $3.50, and it's generally been a slide down to the $1.60-$1.70 range recently. There have been some bumps and wiggles along the way, but the overall direction has been south. However, in the very recent days, it seems to have flattened out a bit, hovering around that lower level.

Now, what's interesting is what the AI is predicting. They're suggesting pretty much no change for today, but then a small bump up of around 2-3% for the next couple of days. So, while the recent trend has been down, the AI is hinting at a possible slight upward turn soon.

Outlook & Ideas: Wait and See, But Keep an Eye Out

Putting it all together, what's the vibe? It feels like we're at a bit of a crossroads for AADI. The stock price has been weak recently, but the upcoming earnings announcement could be a catalyst for change – for better or worse. The AI prediction is mildly positive short-term, but it's just a prediction.

So, what might be a reasonable approach here? For someone looking at AADI, "patience" might be the keyword right now. It's probably wise to hold off on making any big moves until we actually see those earnings results and hear what the company says in their webcast. That information will give a much clearer picture of where things might be headed.

If you're thinking about getting in, and the earnings news turns out to be surprisingly positive, then maybe look for a potential entry point around the current price level of $1.60-$1.70. Why there? Because it's where the stock seems to have found some recent stability. Of course, this is only if the news is good!

On the flip side, for risk management, if you were already holding AADI and getting a bit nervous about the downtrend, you might think about a stop-loss somewhere below the recent lows, perhaps around $1.50 or even a bit lower, just to protect yourself if the price decides to keep falling.

Key thing to remember: Aadi Bioscience is in the biotech business. They're working on cancer treatments. This sector can be exciting but also pretty volatile. News about drug development, approvals, and of course, financial performance, can really move these stocks. So, keep an eye on those kinds of updates.

In short: Earnings are coming. Recent price down, but AI hints at a small bounce. Best to wait for more information before making big decisions. If interested, watch the $1.60-$1.70 area for potential entry if news is good. Consider a stop-loss below recent lows for risk control.


Disclaimer: This analysis is for informational purposes only and should not be taken as financial advice. I'm just breaking down publicly available data in a simple way. Investing in the stock market involves risk, and you could lose money. Always do your own thorough research or talk to a qualified financial advisor before making any investment decisions.

相关新闻

PR Newswire

Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update

Aadi Bioscience, Inc. (Nasdaq: AADI) ("Aadi") today announced that it will host a webcast to discuss fourth quarter and full-year 2024 financial...

查看更多
Aadi Bioscience to Report Fourth Quarter and Full-Year 2024 Results and Corporate Update

AI预测Beta

AI建议

看涨

更新于: 2025年4月28日 00:35

看跌中性看涨

63.9% 置信度

风险与交易

风险等级3/5
中风险
适合于
价值增长
交易指南

入场点

$2.05

止盈点

$2.29

止损点

$1.84

关键因素

DMI显示看跌趋势(ADX:13.8,+DI:18.8,-DI:21.1),表明需谨慎
交易量是平均值的2.6倍(6,328),表明有显著的买入兴趣
MACD -0.0085高于信号线-0.0092,表明看涨交叉

保持更新

设置价格提醒,获取AI分析更新和实时市场新闻。